NOVELION THERAPEUTICS INC's ticker is and the CUSIP is 67001K902. A total of 1 filers reported holding NOVELION THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $14,000 | +250.0% | 19,000 | +280.0% | 0.00% | – |
| Q2 2019 | $4,000 | -86.2% | 5,000 | -49.0% | 0.00% | – |
| Q3 2018 | $29,000 | +625.0% | 9,800 | +880.0% | 0.00% | – |
| Q1 2018 | $4,000 | +33.3% | 1,000 | 0.0% | 0.00% | – |
| Q4 2017 | $3,000 | -98.8% | 1,000 | -96.2% | 0.00% | -100.0% |
| Q2 2017 | $245,000 | +1431.2% | 26,500 | +1666.7% | 0.00% | – |
| Q1 2017 | $16,000 | -88.7% | 1,500 | -91.0% | 0.00% | -100.0% |
| Q4 2016 | $141,000 | – | 16,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |